Conlon CP - Search Results

1

Conlon CP, Peto TE. Conlon CP, et al. Int J Colorectal Dis. 1990 Dec;5(4):236-40. doi: 10.1007/BF00303284. Int J Colorectal Dis. 1990. PMID: 2286809 Review. No abstract available.

2

Runway malaria.

Conlon CP, Berendt AR, Dawson K, Peto TE. Conlon CP, et al. Lancet. 1990 Feb 24;335(8687):472-3. doi: 10.1016/0140-6736(90)90704-9. Lancet. 1990. PMID: 1968192 No abstract available.

3

Impact of waterborne outbreak of cryptosporidiosis on AIDS and renal transplant patients.

Clifford CP, Crook DW, Conlon CP, Fraise AP, Day DG, Peto TE. Clifford CP, et al. Among authors: conlon cp. Lancet. 1990 Jun 16;335(8703):1455-6. doi: 10.1016/0140-6736(90)91478-s. Lancet. 1990. PMID: 1972222 No abstract available.

4

Post-tropical screening. Is of little value..

Conlon CP, Peto T. Conlon CP, et al. BMJ. 1993 Oct 16;307(6910):1008. doi: 10.1136/bmj.307.6910.1008-b. BMJ. 1993. PMID: 8241893 Free PMC article. No abstract available.

5

Safe intravenous antibiotic therapy at home: experience of a UK based programme.

Kayley J, Berendt AR, Snelling MJ, Moore H, Hamilton HC, Peto TE, Crook DW, Conlon CP. Kayley J, et al. Among authors: conlon cp. J Antimicrob Chemother. 1996 May;37(5):1023-9. doi: 10.1093/jac/37.5.1023. J Antimicrob Chemother. 1996. PMID: 8737154

6

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.

Chiodini PL, Conlon CP, Hutchinson DB, Farquhar JA, Hall AP, Peto TE, Birley H, Warrell DA. Chiodini PL, et al. Among authors: conlon cp. J Antimicrob Chemother. 1995 Dec;36(6):1073-8. doi: 10.1093/jac/36.6.1073. J Antimicrob Chemother. 1995. PMID: 8821609 Clinical Trial.

7

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.

Hamlyn E, Hickling S, Porter K, Frater J, Phillips R, Robinson M, Mackie NE, Kaye S, McClure M, Fidler S; SPARTAC Investigators. Hamlyn E, et al. AIDS. 2012 Apr 24;26(7):887-90. doi: 10.1097/QAD.0b013e328351e721. AIDS. 2012. PMID: 22313951

8

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.

Hamlyn E, Ewings FM, Porter K, Cooper DA, Tambussi G, Schechter M, Pedersen C, Okulicz JF, McClure M, Babiker A, Weber J, Fidler S; INSIGHT SMART and SPARTAC Investigators. Hamlyn E, et al. PLoS One. 2012;7(8):e43754. doi: 10.1371/journal.pone.0043754. Epub 2012 Aug 31. PLoS One. 2012. PMID: 22952756 Free PMC article. Clinical Trial.

9

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.

Yager N, Robinson N, Brown H, Flanagan P, Frater J, Fidler S, Weber J, Phillips R; SPARTAC Trial Investigators. Yager N, et al. AIDS. 2013 Jan 28;27(3):313-23. doi: 10.1097/QAD.0b013e32835b8cf5. AIDS. 2013. PMID: 23095315

10

Short-course antiretroviral therapy in primary HIV infection.

SPARTAC Trial Investigators; Fidler S, Porter K, Ewings F, Frater J, Ramjee G, Cooper D, Rees H, Fisher M, Schechter M, Kaleebu P, Tambussi G, Kinloch S, Miro JM, Kelleher A, McClure M, Kaye S, Gabriel M, Phillips R, Weber J, Babiker A. SPARTAC Trial Investigators, et al. N Engl J Med. 2013 Jan 17;368(3):207-17. doi: 10.1056/NEJMoa1110039. N Engl J Med. 2013. PMID: 23323897 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters